BACK<<     
 
 
Sunshine Biopharma, inc.
  SYMBOL: ( OTCBB: SBFM)
 
Steve N. Slilaty   Camille Sebaaly
Chairman, CEO, and President   Chief Financial Officer
 
Interviewed On: Sat, Jan 21 2012
  Interview Formats: Real Audio
Windows Media
  Other Options:
   
 
 
 
 
   INSTITUTIONAL OWNERSHIP / ANALYST COVERAGE
   
   OTHER INFORMATION
   
   COMPANY PROFILE  
 

Sunshine Biopharma, Inc. is a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer.

Cancer Institute estimates that about ten million Americans have or have had some form of cancer. The overall cost of disease treatment is over $126 billion annually. Pharmaceutical companies are developing more than 300 new medicines for cancer, some of which are in development for more than one type of the disease, for a total of more than 500 ongoing R&D projects.

 
 
   COMPANY PRESS RELEASE
 
 
01/21/11
-Sunshine Biopharma and Binghamton University (State University of New York) Enter Into Research Agreement 
 
10/13/10
-Sunshine Biopharma, Inc. Begins Drug Development Activities 
   KEY PRODUCTS / SERVICES  
   
 
   
   
 
Copyright © 2001-2017. All Rights Reserved. Disclaimer | Privacy Policy